Morikubo, Hiromu
Tojima, Ryuta
Maeda, Tsubasa
Matsuoka, Katsuyoshi
Matsuura, Minoru
Miyoshi, Jun
Tamura, Satoshi
Hisamatsu, Tadakazu
Funding for this research was provided by:
The Japan Sciences Research Grant for Research on Intractable Diseases
Article History
Received: 4 October 2023
Accepted: 20 February 2024
First Online: 22 February 2024
Competing interests
: Hiromu Morikubo has received grant support from Takeda Pharmaceutical, Japan Foundation for Applied Enzymology. Katsuyoshi Matsuoka has received speaker fees from Mitsubishi Tanabe Pharma, Takeda Pharmaceutical, Janssen, AbbVie, EA Pharma, Pfizer Inc., Mochida Pharmaceutical, Kyorin Pharmaceutical, Zeria Pharmaceutical, Kissei Pharmaceutical, Gilead Sciences, Eli Lilly, and JIMRO; and received research grants from Mitsubishi Tanabe Pharma, Mochida Pharmaceutical, Kyorin Pharmaceutical, AbbVie, Nippon Kayaku, EA Pharma, Kissei Pharmaceutical, and JIMRO Co. Minoru Matsuura has received consulting and lecture fees from Janssen Pharmaceutical K.K., Takeda Pharmaceutical Co., Ltd., AbbVie GK, Mitsubishi Tanabe Pharma Corporation, Kyorin Pharmaceutical Co., Ltd., Mochida Pharmaceutical Co., Ltd., JIMRO Co., Nippon Kayaku Co., Ltd., Mylan EPD G.K., and Aspen Japan Co., Ltd. Jun Miyoshi has received grant support from AbbVie GK; and received consulting and lecture fees from EA Pharma Co., Ltd., AbbVie GK, Janssen Pharmaceutical K.K., Jansen Asia Pacific Pte. Ltd., Pfizer Inc., Mitsubishi Tanabe Pharma Corporation, JIMRO Co., Miyarisan Co., Ltd., and Takeda Pharmaceutical Co., Ltd. Tadakazu Hisamatsu has performed Joint Research with Alfresa Pharma Co., Ltd., and EA Pharma Co., Ltd.; received grant support from Mitsubishi Tanabe Pharma Corporation, EA Pharma Co., Ltd., AbbVie GK, JIMRO Co., Ltd., Zeria Pharmaceutical Co., Ltd., Daiichi-Sankyo, Kyorin Pharmaceutical Co., Ltd., Nippon Kayaku Co., Ltd., Takeda Pharmaceutical Co., Ltd., Pfizer Inc., and Mochida Pharmaceutical Co., Ltd.; and received consulting and lecture fees from EA Pharma Co., Ltd., AbbVie GK, Celgene K.K., Janssen Pharmaceutical K.K., Pfizer Inc., Nichi-Iko Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Kyorin Pharmaceutical Co., Ltd., JIMRO Co., Mochida Pharmaceutical Co., Ltd., and Takeda Pharmaceutical Co., Ltd. Ryuta Tojima, Tsubasa Maeda, and Satoshi Tamura have no conflicts of interest.